Bioorganic & Medicinal Chemistry Letters

基本信息

期刊简写: BIOORG MED CHEM LETT
影响因子: 2.5
ISSN: 0960-894X
研究领域: MEDICAL
h-index: 133
自引率: 4%
年发文量: 288

SCI收录来源: Science Citation Index Expanded
期刊官网: https://www.sciencedirect.com/journal/bioorganic-and-medicinal-chemistry-letters
期刊介绍:

BMCL (Bioorganic & Medicinal Chemistry Letters) publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with concise review articles and perspectives. BMCL publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of BMCL is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. BMCL continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials. BMCL welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets The reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting Manuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.

CiteScore

CiteScore
5.7
SJR
0.508
SNIP
0.631
学科 排名 百分位
Pharmacology, Toxicology and PharmaceuticsPharmaceutical Science
61 / 183 66%

期刊统计

Semimonthly
期/年
Time to first decision: 5days Review time: 56days Submission to acceptance: 60days Acceptance to publication: 4days
审稿周期
$3770
论文处理费

投稿信息

投稿网址:

https://www.editorialmanager.com/BMCL

相关文献

Site-specific solvation determined by intermolecular nuclear Overhauser effect—measurements and molecular dynamics

Manuel Angulo, Christoph Hawat, Hans-Jörg Hofmann, Stefan Berger

2003-02-13 Paper

DOI: 10.1039/B211134A

Generation and precise control of sulfonyl radicals: visible-light-activated redox-neutral formation of sulfonates and sulfonamides

Mingjun Zhang, Xin Ding, Aidang Lu, Jin Kang, Yongyue Gao, Ziwen Wang, Hongyan Li, Qingmin Wang

2020-12-30 Research Article

DOI: 10.1039/D0QO01413C

Rhodium-catalyzed sequential intermolecular hydroacylation and deconjugative isomerization toward diversified diketones

Zhi-Xin Chang, Jizhong Yan, Chengcai Xia, Fu-Rong Li, Hong-Shuang Li

2020-11-03 Research Article

DOI: 10.1039/D0QO01174F

Theoretical study of rhodium- and cobalt-catalyzed decarboxylative transformations of isoxazolones: origin of product selectivity

Wei Rong, Tian Zhang, Ting Li, Juan Li

2021-01-26 Research Article

DOI: 10.1039/D0QO01498B

Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites

Alireza Sardarian, Kenneth T. Douglas, Martin Read, Paul F. G. Sims, John E. Hyde, Penchit Chitnumsub, Rachada Sirawaraporn, Worachart Sirawaraporn

2003-02-25 Paper

DOI: 10.1039/B211636G

The chemical synthesis of β-(1→4)-linked D-mannobiose and D-mannotriose

Gavin W. J. Twaddle, Dmitry V. Yashunsky, Andrei V. Nikolaev

2003-01-30 Paper

DOI: 10.1039/B210661M

Synthesis of isoxazolidines via catalyst-free one-pot three-component cycloaddition of sulfoxonium ylides, nitrosoarenes and alkenes

Xing Li, Pingan Zhai, Yongsheng Fang, Wenhui Li, Honghong Chang, Wenchao Gao

2021-01-12 Research Article

DOI: 10.1039/D0QO01471K

您可能还喜欢

化合物问答

4-[4-三氟甲基苯基]恶唑(CAS号:1126636-40-5)通常如何合成?

4-[4-三氟甲基苯基]恶唑通常通过将4-三氟甲基苯酚与异硫氰酸苯酯在有机溶剂中进行酯化反应合成。该反应可在无水条件下,使用适当的催化剂,如四丁基氢氧化铵,以提...

1126636-40-54-(4-(Trifluoromethy...
化合物问答

氢溴酸西酞普兰(CAS号:59729-32-7)的主要用途是什么?

氢溴酸西酞普兰主要用于治疗抑郁症,通过调节大脑中的神经递质平衡来改善情绪。

59729-32-71-[3-(Dimethylamino)...
化合物问答

RockPhos Pd G3(CAS号:2009020-38-4)通常如何合成?

RockPhos Pd G3 通常通过钯催化偶联反应合成,使用配体 (2'-Amino-2-biphenylyl)(methanesulfonato-kappa...

2009020-38-4(2'-Amino-2-biphenyl...
化合物问答

1-哌啶甲酰胺(CAS号:2158-03-4)的市场或研究趋势如何?

1-哌啶甲酰胺作为有机合成中的重要中间体,其市场需求主要受医药、农药、染料等行业推动。近年来,随着新药开发和绿色化学的发展,该化合物的研究趋势集中在开发更高效、...

2158-03-41-Piperidinecarboxam...
化合物问答

2-(二苯基膦基)乙胺(CAS号:4848-43-5)适用哪些法规指南?

2-(二苯基膦基)乙胺适用于多种法规指南,包括但不限于《全球化学品统一分类和标签制度》(GHS),欧盟《化学品注册、评估、授权和限制》法规(REACH),以及美...

4848-43-52-(Diphenylphosphino...
化合物问答

如何储存间苯二甲酸二烯丙酯(CAS号:1087-21-4)?

间苯二甲酸二烯丙酯应储存在阴凉、干燥、通风良好的地方,远离火源和热源。储存容器应密封,避免光照和高温。储存温度应控制在25℃以下,相对湿度应低于80%。避免与其...

1087-21-4Diallyl isophthalate
化合物问答

什么是间甲苯异硫代异氰酸酯(CAS号:621-30-7)?

间甲苯异硫代异氰酸酯是一种有机化合物,分子式为C7H7NO2S,具有刺激性气味。它是一种重要的有机合成中间体,在合成其他化合物时广泛应用。

621-30-71-Isothiocyanato-3-m...
化合物问答

在合成中是否有N-Boc-D-苯丙氨醇(CAS号:106454-69-7)的替代品?

在合成中,可以考虑使用N-Cbz-D-苯丙氨醇或N-Fmoc-D-苯丙氨醇作为替代品。这些化合物同样具有保护氨基的功能,且在合成过程中表现出良好的反应性能。

106454-69-72-Methyl-2-propanyl ...
化合物问答

3-羟甲基-2-氧异丙基吡啶(CAS号:954240-50-7)的主要用途是什么?

3-羟甲基-2-氧异丙基吡啶主要用于有机合成领域,可以作为合成其他药物、农药或精细化学品的中间体。此外,它还可能在实验室研究中作为特定反应的前体或溶剂。

954240-50-7(2-Isopropoxy-3-pyri...
化合物问答

6-氨基-9-甲基嘌呤(CAS号:700-00-5)应用于哪些行业?

6-氨基-9-甲基嘌呤目前主要应用于医药行业,作为某些药物的中间体。此外,它还可能用于聚合物、传感器和半导体的某些领域,作为功能性单体或掺杂剂。

700-00-59-Methyl-9H-purin-6-...
免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。